Lydia Jordan

Principal Investigator CGT Supply Chain • GlaxoSmithKline

Lydia Jordan is a Principal Investigator in CGT Supply Chain at GSK.  She is responsible for implementation, compliance, and management of Cell Therapy Operations in the US and Canada markets for cell and gene therapy clinical trials.   

Her 15+ year career at GSK spans drug discovery, CMC and clinical supply with a focus on innovations and advancement in medicine development.

Also Speaking

Anne Rowzee

Associate Director for Policy, Office of Tissues and Advanced Therapies • FDA

Olivier Negre

Chief Scientific Officer • Smart-Immune

Ian Gaudet

Senior Director, Site Head San Jose • Miltenyi Biotec

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.